Trial Profile
Clinical Trials Insight: 700012952
Status:
Not yet recruiting
Phase of Trial:
Phase I
Latest Information Update: 24 Apr 2006
Price :
$35
*
At a glance
- Drugs NBI 75043 (Primary)
- Indications Insomnia
- Focus Therapeutic Use
- Sponsors Neurocrine Biosciences
- 24 Apr 2006 New trial record.